• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Comment on "Antipsoriatic treatments during COVID-19 outbreak".关于“新冠肺炎疫情期间的银屑病治疗”的评论
Dermatol Ther. 2020 Jul;33(4):e13491. doi: 10.1111/dth.13491. Epub 2020 Jun 12.
2
Antipsoriatic treatments during COVID-19 outbreak.新冠疫情期间的银屑病治疗
Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10.
3
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
4
Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.2019冠状病毒病疫情期间银屑病的生物治疗：选择需权衡风险与获益。
Dermatol Ther. 2020 Jul;33(4):e13490. doi: 10.1111/dth.13490. Epub 2020 May 20.
5
Biologics for psoriasis in COVID-19 era: What do we know?新冠疫情时代用于治疗银屑病的生物制剂：我们了解什么？
Dermatol Ther. 2020 Jul;33(4):e13467. doi: 10.1111/dth.13467. Epub 2020 Jun 15.
6
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
7
COVID-19 in an elderly patient treated with secukinumab.一位接受司库奇尤单抗治疗的老年患者的新型冠状病毒肺炎
Dermatol Ther. 2020 Jul;33(4):e13580. doi: 10.1111/dth.13580. Epub 2020 May 27.
8
Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.银屑病、新冠病毒肺炎与急性呼吸窘迫综合征：关注联合生物治疗的风险
Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19.
9
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.在新冠疫情期间，银屑病的生物治疗并非一种选择。
J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6.
10
Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.银屑病患者的机会性病毒感染：在新冠疫情时代阿普米拉斯更安全的选择。
Dermatol Ther. 2020 Jul;33(4):e13618. doi: 10.1111/dth.13618. Epub 2020 Jun 4.

引用本文的文献

1
Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?2019年冠状病毒病大流行对慢性炎症性免疫介导性皮肤病病程及管理的影响：有哪些证据？
Clin Dermatol. 2021 Jan-Feb;39(1):52-55. doi: 10.1016/j.clindermatol.2020.12.012. Epub 2020 Dec 15.

本文引用的文献

1
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
2
Antipsoriatic treatments during COVID-19 outbreak.新冠疫情期间的银屑病治疗
Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10.
3
Risk of hospitalization and death due to infection in people with psoriasis: a population-based cohort study using the Clinical Practice Research Datalink.银屑病患者因感染而住院和死亡的风险：一项基于人群的队列研究，使用临床实践研究数据链。
Br J Dermatol. 2021 Jan;184(1):78-86. doi: 10.1111/bjd.19052. Epub 2020 May 12.
4
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.关于严重皮肤病患者的新型冠状病毒肺炎及免疫调节剂使用的建议。
Australas J Dermatol. 2020 May;61(2):158-159. doi: 10.1111/ajd.13295. Epub 2020 Apr 14.
5
Older adults on systemic treatment for psoriasis and risk of infection: a propensity score-matched population-based study.接受银屑病系统治疗的老年人与感染风险：一项倾向评分匹配的基于人群的研究。
Br J Dermatol. 2020 Sep;183(3):564-566. doi: 10.1111/bjd.19028. Epub 2020 May 15.
6
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
7
Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds.呼吸道病毒感染会引发不同临床亚型和遗传背景下的急性银屑病发作。
Br J Dermatol. 2019 Dec;181(6):1304-1306. doi: 10.1111/bjd.18203. Epub 2019 Aug 20.
8
Long-term safety and drug survival of acitretin in psoriasis: a retrospective observational study.阿维 A 治疗银屑病的长期安全性和药物存续性：一项回顾性观察研究。
Int J Dermatol. 2019 May;58(5):593-599. doi: 10.1111/ijd.14349. Epub 2018 Dec 13.
9
Psoriasis and infection. A clinical practice narrative.银屑病与感染。临床实践叙事。
Australas J Dermatol. 2019 May;60(2):91-98. doi: 10.1111/ajd.12895. Epub 2018 Aug 5.
10
Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study.阿达木单抗每周 40 毫克剂量治疗对每两周 40 毫克剂量治疗应答不佳的银屑病患者的疗效、安全性和药物费用影响：一项开放标签研究的结果。
Br J Dermatol. 2012 Sep;167(3):658-67. doi: 10.1111/j.1365-2133.2012.11041.x. Epub 2012 Aug 20.

Comment on "Antipsoriatic treatments during COVID-19 outbreak".

作者信息

Abdelmaksoud Ayman, Goldust Mohamad, Vestita Michelangelo

机构信息

Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.

Department of Dermatology, University of Rome G. Marconi, Rome, Italy.

出版信息

Dermatol Ther. 2020 Jul;33(4):e13491. doi: 10.1111/dth.13491. Epub 2020 Jun 12.

DOI:10.1111/dth.13491
PMID:32358882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7261973/
Abstract
摘要